GridAI Technologies Corp. (GRDX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, GridAI Technologies Corp. (GRDX) has a cash flow conversion efficiency ratio of -0.065x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.79 Million) by net assets ($27.49 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See GridAI Technologies Corp. (GRDX) net asset quality to measure how much of total assets are equity-financed.
GridAI Technologies Corp. - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how GridAI Technologies Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check GRDX cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
GridAI Technologies Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GridAI Technologies Corp. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Watches Of Switzerland Group PLC
LSE:WOSG
|
0.148x |
|
BeMetals Corp
V:BMET
|
-0.057x |
|
Sakthi Sugars Limited
NSE:SAKHTISUG
|
-0.073x |
|
Flap Kongre Toplanti Hizmetleri Otomotiv ve Turizm AS
IS:FLAP
|
-0.004x |
|
Lumens Co. Ltd
KQ:038060
|
0.074x |
|
Elevation Oncology Inc
NASDAQ:ELEV
|
-0.272x |
|
Vikas EcoTech Limited
NSE:VIKASECO
|
-0.032x |
|
SynCore Biotechnology Co Ltd
TWO:4192
|
-0.028x |
Annual Cash Flow Conversion Efficiency for GridAI Technologies Corp. (2013–2025)
The table below shows the annual cash flow conversion efficiency of GridAI Technologies Corp. from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see GridAI Technologies Corp. (GRDX) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $28.83 Million | $-5.70 Million | -0.198x | -24.03% |
| 2024-12-31 | $57.80 Million | $-9.22 Million | -0.159x | +95.36% |
| 2023-12-31 | $3.60 Million | $-12.38 Million | -3.435x | +57.84% |
| 2022-12-31 | $2.74 Million | $-22.34 Million | -8.148x | -297.39% |
| 2021-12-31 | $-7.82 Million | $-32.29 Million | 4.128x | -2.86% |
| 2020-12-31 | $-2.64 Million | $-11.22 Million | 4.249x | +239.81% |
| 2019-12-31 | $4.62 Million | $-14.03 Million | -3.039x | -25.10% |
| 2018-12-31 | $4.47 Million | $-10.87 Million | -2.430x | +7.63% |
| 2017-12-31 | $2.73 Million | $-7.18 Million | -2.630x | -86.35% |
| 2016-12-31 | $3.21 Million | $-4.53 Million | -1.411x | -222.85% |
| 2015-12-31 | $-3.63 Million | $-4.17 Million | 1.149x | +402.06% |
| 2014-12-31 | $2.64 Million | $-1.01 Million | -0.380x | -631001.74% |
| 2013-12-31 | $-938.31K | $56.55 | 0.000x | -- |
About GridAI Technologies Corp.
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in … Read more